A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin"s lymphoma.

A Engert; R Schnell; F Küpper; M Reiser; M Engelhard; Martin Wilhelm; B Lathan; S Baltes-Engler; B Winterhalter; M E Scheulen; B Dederichs; H Tesch; B Wörmann; V Diehl

doi:10.3109/10428199709055588

A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin"s lymphoma.

A Engert, R Schnell, F Küpper, M Reiser, M Engelhard, Martin Wilhelm (Co-author), B Lathan, S Baltes-Engler, B Winterhalter, M E Scheulen, B Dederichs, H Tesch, B Wörmann, V Diehl

Research output: Contribution to journal › Original Article › peer-review

21 Citations (Web of Science)

Original language	English
Pages (from-to)	513-522
Journal	LEUKEMIA & LYMPHOMA
Volume	24
Issue number	5-6
DOIs	https://doi.org/10.3109/10428199709055588
Publication status	Published - 1997

Keywords

ACUTE MYELOID-LEUKEMIA
INTERMEDIATE-GRADE
CARDIAC TOXICITY
ELDERLY PATIENTS
DOSE CYTARABINE
SALVAGE THERAPY
4-DEMETHOXYDAUNORUBICIN
CHEMOTHERAPY
ETOPOSIDE
REGIMEN

Access to Document

10.3109/10428199709055588

Cite this

Engert, A., Schnell, R., Küpper, F., Reiser, M., Engelhard, M., Wilhelm, M., Lathan, B., Baltes-Engler, S., Winterhalter, B., Scheulen, M. E., Dederichs, B., Tesch, H., Wörmann, B., & Diehl, V. (1997). A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin"s lymphoma. LEUKEMIA & LYMPHOMA , 24(5-6), 513-522. https://doi.org/10.3109/10428199709055588

Engert, A ; Schnell, R ; Küpper, F et al. / A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin"s lymphoma. In: LEUKEMIA & LYMPHOMA 1997 ; Vol. 24, No. 5-6. pp. 513-522.

@article{737158e323b94b928e7755a20d2d1f03,

title = "A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin{"}s lymphoma.",

keywords = "ACUTE MYELOID-LEUKEMIA, INTERMEDIATE-GRADE, CARDIAC TOXICITY, ELDERLY PATIENTS, DOSE CYTARABINE, SALVAGE THERAPY, 4-DEMETHOXYDAUNORUBICIN, CHEMOTHERAPY, ETOPOSIDE, REGIMEN",

author = "A Engert and R Schnell and F K{\"u}pper and M Reiser and M Engelhard and Martin Wilhelm and B Lathan and S Baltes-Engler and B Winterhalter and Scheulen, \{M E\} and B Dederichs and H Tesch and B W{\"o}rmann and V Diehl",

year = "1997",

doi = "10.3109/10428199709055588",

language = "English",

volume = "24",

pages = "513--522",

journal = "LEUKEMIA \& LYMPHOMA ",

issn = "1042-8194",

number = "5-6",

}

Engert, A, Schnell, R, Küpper, F, Reiser, M, Engelhard, M, Wilhelm, M, Lathan, B, Baltes-Engler, S, Winterhalter, B, Scheulen, ME, Dederichs, B, Tesch, H, Wörmann, B & Diehl, V 1997, 'A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin"s lymphoma.', LEUKEMIA & LYMPHOMA , vol. 24, no. 5-6, pp. 513-522. https://doi.org/10.3109/10428199709055588

A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin"s lymphoma. / Engert, A; Schnell, R; Küpper, F et al.
In: LEUKEMIA & LYMPHOMA , Vol. 24, No. 5-6, 1997, p. 513-522.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin"s lymphoma.

AU - Engert, A

AU - Schnell, R

AU - Küpper, F

AU - Reiser, M

AU - Engelhard, M

AU - Wilhelm, Martin

AU - Lathan, B

AU - Baltes-Engler, S

AU - Winterhalter, B

AU - Scheulen, M E

AU - Dederichs, B

AU - Tesch, H

AU - Wörmann, B

AU - Diehl, V

PY - 1997

Y1 - 1997

KW - ACUTE MYELOID-LEUKEMIA

KW - INTERMEDIATE-GRADE

KW - CARDIAC TOXICITY

KW - ELDERLY PATIENTS

KW - DOSE CYTARABINE

KW - SALVAGE THERAPY

KW - 4-DEMETHOXYDAUNORUBICIN

KW - CHEMOTHERAPY

KW - ETOPOSIDE

KW - REGIMEN

U2 - 10.3109/10428199709055588

DO - 10.3109/10428199709055588

M3 - Original Article

C2 - 9086441

SN - 1042-8194

VL - 24

SP - 513

EP - 522

JO - LEUKEMIA & LYMPHOMA

JF - LEUKEMIA & LYMPHOMA

IS - 5-6

ER -

Engert A, Schnell R, Küpper F, Reiser M, Engelhard M, Wilhelm M et al. A phase-II study with idarubicin, ifosfamide and VP-16 (IIVP-16) in patients with refractory or relapsed aggressive and high grade non-Hodgkin"s lymphoma. LEUKEMIA & LYMPHOMA . 1997;24(5-6):513-522. doi: 10.3109/10428199709055588